Patents expiring in 2028

US 7439323

Cysteine-containing peptides having antioxidant properties

The Regents of the University of California · Granted Tue Oct 21 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 16 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7439045

pH controlled fermentation process for pseudomonic acid production

TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság · Granted Tue Oct 21 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 16 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7439013

Biocompatible polymer and filter for selectively eliminating leucocytes using the same

ASAHI KASEI KURARAY MEDICAL CO., LTD. · Granted Tue Oct 21 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 16 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7438915

Immunopotentiating effect of a Fomitella fraxinea-derived lectin on chicken immunity and resistance to coccidiosis

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Oct 21 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 16 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7439226

Serine protease inhibitors

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 21 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 16 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7439252

Ascomycin crystalline forms and preparation thereof

TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság · Granted Tue Oct 21 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 16 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7439231

Inhibitors of antigen presentation by MHC class II molecules and methods of use thereof

Provid Pharmaceuticals Inc. · Granted Tue Oct 21 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 16 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7439249

Inhibitors of phosphatases

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 21 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 16 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7439265

Irciniastatins a and b

ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue Oct 21 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 16 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7438931

Methods and compositions for the treatment of angiogenic diseases

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Oct 21 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 16 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7438914

Composition and method for enhancing immune response

ARIZONA BOARD OF REGENTS, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue Oct 21 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 16 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7439373

Crystalline mycophenolate sodium

TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság · Granted Tue Oct 21 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 16 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7439399

Processes for the preparation of atomoxetine hydrochloride

Teva Pharmaceutical Fine Chemicals S.R.L. · Granted Tue Oct 21 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 16 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7439398

Enantiomerically pure atomoxetine and tomoxetine mandelate

Teva Pharmaceutical Fine Chemicals S.R.L. · Granted Tue Oct 21 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 16 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7442543

Mammalian selenoprotein differentially expressed in tumor cells

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 28 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 23 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7442718

Inhibitors of aspartyl protease

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 28 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 23 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7442372

Delivery of therapeutic compounds to the brain and other tissues

BIOMARIN PHARMACEUTICAL INC. · Granted Tue Oct 28 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 23 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7442790

Caspase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 28 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 23 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7442806

Processes for preparing darifenacin hydrobromide

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Oct 28 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 23 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7442558

Phthalamide-lanthanide complexes for use as luminescent markers

The Regents of the University of California · Granted Tue Oct 28 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 23 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7442546

Method of modulating inflammatory response

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Oct 28 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 23 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7442391

Bioactive botanical cosmetic compositions and processes for their production

INTEGRATED BOTANICAL TECHNOLOGIES, LLC · Granted Tue Oct 28 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 23 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7442696

Mineralocorticoid receptor modulator compounds, processes for their preparation, and their uses

Ligand Pharmaceuticals Incorporated · Granted Tue Oct 28 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 23 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7446199

Compositions useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Nov 04 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 30 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7445628

Method of treating a patient with a coated implantable medical device

Cook Regentec LLC · Granted Tue Nov 04 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 30 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7445890

Ucp-2 promoter and use thereof

Takeda Pharmaceutical Company Limited · Granted Tue Nov 04 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 30 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7445794

Methods for treating human proliferative diseases, with a combination of fatty acid metabolism inhibitors and glycolytic inhibitors

The Regents of the University of Colorado · Granted Tue Nov 04 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 30 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7446112

Modulators of muscarinic receptors

Vertex Pharmaceuticals Incorporated · Granted Tue Nov 04 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 30 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7446108

Tri-and tetraaza-acenaphthylen derivatives as CRF receptor antagonists

Neurocrine, Inc. · Granted Tue Nov 04 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 30 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7446185

Her2/neu target antigen and use of same to stimulate an immune response

The Regents of the University of California · Granted Tue Nov 04 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 30 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7446124

Wortmannin analogs and methods of using same in combination with chemotherapeutic agents

Arizona Board of Regents, Acting on Behalf of the University of Arizona · Granted Tue Nov 04 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 30 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7446114

Quinolinone compounds as 5-HT4 receptor agonists

Theravance, Inc. · Granted Tue Nov 04 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 30 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7446182

Recombinant antibodies for the detection and neutralization of anthrax toxin

The Board of Regents of the University of Texas System · Granted Tue Nov 04 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 30 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7449182

Therapeutic combination of a VEGF antagonist and anti-hypertensive agent

REGENERON PHARMACEUTICALS, INC. · Granted Tue Nov 11 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7449190

Assays for assembly of Ebola virus nucleocapsids

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 11 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7449323

Hemorrhagic feline calicivirus

The Regents of the University of California · Granted Tue Nov 11 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7449458

Prodrugs of 2,4-pyrimidinediamine compounds and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue Nov 11 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7449202

Compositions and methods for prostate and kidney health and disorders, an herbal preparation

Integrated Chinese Medicine Holdings Ltd. · Granted Tue Nov 11 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7449201

Storage stable power compositions of interleukin-4 receptor

Nektar Therapeutics · Granted Tue Nov 11 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7449557

Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy

University of Connecticut Health Center · Granted Tue Nov 11 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7449171

Measurement of biosynthesis and breakdown rates of biological molecules that are inaccessible or not easily accessible to direct sampling, non-invasively, by label incorporation into metabolic derivatives and catabolic products

The Regents of the University of California · Granted Tue Nov 11 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7449570

Use of nucleoside compounds for nonsense suppression and the treatment of genetic diseases

PTC THERAPEUTICS, INC. · Granted Tue Nov 11 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7449444

Hydroxyethyl starch-containing polypeptide compositions

The Regents of the University of Colorado · Granted Tue Nov 11 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7449192

Use of neurotoxin therapy for treatment of urologic and related disorders related to neurogenic bladder dysfunction

The Regents of the University of Colorado · Granted Tue Nov 11 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7452971

Compositions and methods for modifying toxic effects of proteinaceous compounds

The Board of Regents of the University of Texas System · Granted Tue Nov 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7452995

Aryl aniline β2 adrenergic receptor agonists

Theravance, Inc. · Granted Tue Nov 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7452964

Compositions and methods of use of targeting peptides against placenta and adipose tissues

The Board of Regents of the University of Texas System · Granted Tue Nov 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7452898

Phosphonate compounds

The Regents of the University of California · Granted Tue Nov 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)